2 Firms Help Swedish Drug Co. Sobi Raise $540M
Swedish biopharmaceutical business Sobi has raised 6.024 billion Swedish kronor ($540 million) through an oversubscribed rights issue, to help to repay a loan taken out to fund the $1.7 billion acquisition...To view the full article, register now.
Already a subscriber? Click here to view full article